Submit your email to push it up the queue
Abbott Diagnostics GmbH, a subsidiary of Abbott Laboratories, is a leading player in the global diagnostics industry, headquartered in Germany. Established in 1888, the company has consistently innovated in the field of medical diagnostics, focusing on areas such as immunoassay, molecular diagnostics, and point-of-care testing. With a strong presence in Europe and beyond, Abbott Diagnostics is renowned for its cutting-edge products, including the ARCHITECT and Alinity systems, which enhance laboratory efficiency and accuracy. The company’s commitment to advancing healthcare through innovative solutions has solidified its market position, making it a trusted partner for healthcare providers worldwide. Abbott Diagnostics continues to set benchmarks in the industry, driven by a legacy of excellence and a focus on improving patient outcomes.
How does Abbott Diagnostics GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abbott Diagnostics GmbH's score of 56 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abbott Diagnostics GmbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Abbott Laboratories, which cascades its climate commitments and targets down to its subsidiaries. Abbott Laboratories has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, which are relevant to Abbott Diagnostics GmbH. However, specific reduction targets or achievements for Abbott Diagnostics GmbH are not detailed in the available data. As a subsidiary, Abbott Diagnostics GmbH aligns with the broader sustainability goals set by Abbott Laboratories, which may include commitments to reduce greenhouse gas emissions across Scope 1, 2, and 3 categories. The absence of specific emissions data suggests that the company is in the process of developing or implementing its own climate strategies in line with its parent company's initiatives. In summary, while Abbott Diagnostics GmbH does not currently report specific emissions figures, it is part of a corporate family that is actively engaged in climate commitments through Abbott Laboratories, which may influence its future sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abbott Diagnostics GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.